Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements

Breast Cancer Research

Volumn 16, Issue 5, 2014, Pages

  Hsiung, Chia Ni ^a,b   Chu, Hou Wei ^a,b   Huang, Yuan Ling ^a   Chou, Wen Cheng ^a   Hu, Ling Yueh ^a   Hsu, Huan Ming ^c   Wu, Pei Ei ^a,b   Hou, Ming Feng ^d   Yu, Jyh Cherng ^c   Shen, Chen Yang ^a,b,e  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 21Q; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; BREAST TUMOR; CHROMOSOME 21; DISEASE COURSE; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; KAPLAN MEIER METHOD; LOD SCORE; MCF 7 CELL LINE; MORTALITY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

ESTROGEN; ESTROGEN RECEPTOR ALPHA;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 21; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME, HUMAN; HUMANS; KAPLAN-MEIER ESTIMATE; LOD SCORE; MCF-7 CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RESPONSE ELEMENTS; SEQUENCE ANALYSIS, DNA;

EID: 84938567761     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-014-0455-1     Document Type: Article

References (34)

1. Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282.
2. Osborne CK, Schiff R: Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005, 23:1616-1622.
3. Green KA, Carroll JS: Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 2007, 7:713-722.
4. Shang Y: Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006, 6:360-368.
5. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartek F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004, 119:591-602.
6. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R: A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000, 60:873-876.
7. Yu JC, Hsiung CN, Hsu HM, Bao BY, Chen ST, Hsu GC, Chou WC, Hu LY, Ding SL, Cheng CW, Wu PE, Shen CY: Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Res 2011, 13:R13.
8. Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS: Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393.
9. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, Palanisamy N, Miller LD, Cheung E, Katzenellenbogen BS, Ruan Y, Bourque G, Wei CL, Liu ET: Whole-genome cartography of estrogen receptor aα binding sites. PLoS Genet 2007, 3:e87.
10. Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FCGJ, Span PN, Stunnenberg HG: ChIP-Seq of ERaα and RNA polymerase II defines genes differentially responding to ligands. EMBO J 2009, 28:1418-1428.
11. Ding SL, Yu JC, Chen ST, Hsu GC, Hsu HM, Ho JY, Lin YH, Chang CC, Fann SJ, Cheng CW, Wu PE, Shen CY: Diverse associations between ESR1 polymorphism and breast cancer development and progression. Clin Cancer Res 2010, 16:3473-3484.
12. Ding SL, Yu JC, Chen ST, Hsu GC, Kuo SJ, Lin YH, Wu PE, Shen CY: Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 2009, 30:43-49.
13. Ding SL, Yu JC, Chen ST, Hsu GC, Shen CY: Genetic variation in the premature aging gene WRN : a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007, 16:263-269.
14. Taiwan Biobank. [ https://taiwanview.twbiobank.org.tw/taiwanview/twbinfo.do ] (accessed 14 October 2014).
15. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, The Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L, dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M, et al: Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013, 45:353-361.
16. Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, Choi JY, Long J, Dennis J, Humphreys MK, Wang Q, Lu W, Gao YT, Li C, Cai H, Park SK, Yoo KY, Noh DY, Han W, Dunning AM, Benitez J, Vincent D, Bacot F, Tessier D, Kim SW, Lee MH, Lee JW, Lee JY, Xiang YB, Zheng Y: Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet 2013, 22:2539-2550.
17. Browning BL: PRESTO: rapid calculation of order statistic distributions and multiple-testing adjusted P-values via permutation for one and two-stage genetic association studies. BMC Bioinformatics 2008, 9:309.
18. Barrett JC, Fry B, Maller J: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
19. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
20. Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, Hsu HM, Wu PE, Hou MF, Shen CY, Yu JC: A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Hum Mol Genet 2014, 23:355-367.
21. Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
22. Cheng YC, Hsiao FC, Yeh EC, Lin WJ, Tang CY, Tseng HC, Wu HT, Liu CK, Chen CC, Chen YT, Yao A: VarioWatch: providing large-scale and comprehensive annotations on human genomic variants in the next generation sequencing era. Nucleic Acids Res 2012, 40(Web Server issue):W76-W81.
23. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B, Chenard MP, Tomasetto C, Rio MC: Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 2011, 30:3261-3273.
24. Scott HS, Kudoh J, Wattenhofer M, Shibuya K, Berry A, Chrast R, Guipponi M, Wang J, Kawasaki K, Asakawa S, Minoshima S, Younus F, Mehdi SQ, Radhakrishna U, Papasavvas MP, Gehrig C, Rossier C, Korostishevsky M, Gal A, Shimizu N, Bonne-Tamir B, Antonarakis SE: Insertion of β-satellite repeats identifies a transmembrane protease causing both congenital and childhood onset autosomal recessive deafness. Nat Genet 2001, 27:59-63.
25. Lee YJ, Park D, Kim SY, Park WJ: Pathogenic mutations but not polymorphisms in congenital and childhood onset autosomal recessive deafness disrupt the proteolytic activity of TMPRSS3. J Med Genet 2003, 40:629-631.
26. The ENCODE Project Consortium: A user's guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biol 2011, 9:e1001046.
27. McEwan MV, Eccles MR, Horsfield JA: Cohesin is required for activation of MYC by estradiol. PLoS One 2012, 7:e49160.
28. Fugger L, McVean G, Bell JI: Genomewide association studies and common disease-realizing clinical utility. N Engl J Med 2012, 367:2370-2371.
29. Dunbier AK, Anderson H, Ghazoui Z, Folkerd EJ, A'Hern R, Crowder RJ, Hoog J, Smith IE, Osin P, Nerurkar A, Parker JS, Perou CM, Ellis MJ, Dowsett M: Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J Clin Oncol 2010, 28:1161-1167.
30. Lin Z, Reierstad S, Huang CC, Bulun SE: Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res 2007, 67:5017-5024.
31. Guerrero K, Wang Z, Bachvarova M, Gregoire J, Renaud MC, Plante M, Bachvarov D: A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation. Gynecol Oncol 2012, 125:720-726.
32. Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE: Are trefoil factors oncogenic? Trends Endocrinol Metab 2008, 19:74-81.
33. Li Y, Sun L, Zhang Y, Wang D, Wang F, Liang J, Gui B, Shang Y: The histone modifications governing TFF1 transcription mediated by estrogen receptor. J Biol Chem 2011, 286:13925-13936.
34. Sajan SA, Hawkins RD: Methods for identifying higher-order chromatin structure. Annu Rev Genomics Hum Genet 2012, 13:59-82.